Summary: Characterization of human cytomegalovirus-specific T cells (CMV-T) is of critical importance for their potential use in adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation. Background frequencies of CMV-T in peripheral blood mononuclear cells (PBMCs) of CMV-seropositive healthy subjects are usually very low, hence the requirement for prolonged culture time and multiple stimulations to expand them. The evaluation of the end-culture specificity and composition has sometimes been neglected or difficult to assess in these settings. We explored the identity and the functionality of pp65-specific and IE1-specific T cells, enriched in short-term cultures from PBMCs. Antigen-specific T cells were further isolated by IFN-g capture system and/or CD154 microbeads. Frequency of IE1-specific cytotoxic T cells in PBMCs secreting IFN-g was higher compared with the pp65-specific one, whereas the latter cell types showed a higher median CD107a degranulation. Cell viability, rate of CMV-T increase, and multicytokine secretion profile after epitope-specific short-term cultures were heterogenous. T cells were mainly of late effector stages but they significantly dropped off upon CMV rechallenge with peptide pools. In parallel, CMV-T expansion was accompanied by a significant increase of cytotoxic naive/memory stem cells (CTLs), whereas the CD4 + counterpart significantly increased only upon stimulation with IE1. Outcome was variable and showed donor and epitope dependency. Differences in human leukocyte antigen and epitope dominance and variability in the relative number of CD3 + effector cells and IFN-g/CD154 expression among healthy donors could reflect the observed individual CMV-specific cellular immunity. This heterogeneity raises points to be considered when approaching adoptive immunotherapy.
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Key Words: allogeneic hematopoietic stem cell transplantation, CMV-seropositive donors, p65-specific and IE1-specific T cells, adoptive immunotherapy (J Immunother 2016;39:329-342) P reemptive and prophylactic strategies are effective in the control of reactivation of latent cytomegalovirus (CMV) occurring in allogeneic hematopoietic stem cell transplantation (HSCT), reducing the incidence of CMV disease to no more than 5%-8%. However, these strategies do not show a definitive improved overall survival in this setting. These poor results may be in part related to the associated toxicities of antiviral drugs as, for example, the myelosuppressive effects of ganciclovir. Furthermore, the advent of prophylaxis caused an alteration in the epidemiology of CMV disease, with an increase in lateonset CMV reactivation so that delayed or impaired anti-CMV immunologic recovery remains a major cause of morbidity. 1, 2 Reconstitution of the host with in vitro-isolated antigen-specific T cells, obtained by a donor with an intact T-cell repertoire, is a potential strategy for preventing and treating this disease. In this setting, restoration of CMV immunity by adoptive transfer of CMV-specific T cells (CMV-T) has been shown to be effective and safe. [3] [4] [5] The goal of current trials based on cellular immunotherapy against CMV is to make treatment with CMV-T more broadly applicable using more rapidly available products from the donor, such as directly selected T lymphocytes. Indeed, increasingly sophisticated strategies show that the beneficial effect of adoptive T-cell transfer (ACT) relies on an in vivo expansion in the presence of the antigen after rapid in vitro isolation. [5] [6] [7] Major drawbacks of these procedures remain the limitation in the characterization of the T-cell product before infusion and the best administration schedule because of the low quantity of T-specific lymphocytes, so that any method to expand these cells to an extent sufficient to carry out experimental work would be really important. In this paper, we aimed to evaluate the biology of antiviral CD4 + and CD8 + T cells in healthy subjects, shortly enriched in vitro upon a single antigenic stimulation with the viral epitopes pp65 and IE1 [mixed lymphocyte-peptide cultures (MLPCs)]. We have assessed the specificity of the cells subjected to expansion, final yield, antigen-specific proliferation and degranulation potential, cytokine secretion patterns, and T-cell subpopulations phenotype. We have compared the results obtained from 8 peripheral blood mononuclear cells (PBMCs) samples from CMVseropositive normal donors after activation with either one or the other CMV antigen. To avoid any bias, we have split each lot from the same donor to perform a legitimate data comparison between the disparate antigen-specific T cells. We focused on the diverse functionality of the respective reactive pp65-specific and IE1-specific T cells. The diversified behavior of these CMV-T cells when applied in adoptive cellular therapies protocols is even more considered as key for the patients' adaptive immunity recovery after HSCT.
MATERIALS AND METHODS

Blood Donors and Cell Samples
Blood samples from 8 CMV-seropositive healthy volunteers were obtained with written informed consent and stored or transported at room temperature (RT). PBMCs were isolated within 4 hours from blood drawing by density gradient separation using Ficoll-Paque Premium (GE Healthcare BioSciences AB, Uppsala, Sweden). Platelets were removed by centrifugation of cells at 200g for 15 minutes at RT. Cells were cryopreserved in RPMI 1640 (Sigma-Aldrich, St Louis, MO) with 50% human serum albumin (Albital 200 g/L; Kedrion, Lucca, Italy) and 10% dimethylsulphoxide (DMSO; Sigma-Aldrich) according to standard protocols, for use in scheduled experiments as well as a source of autologous feeder cells. For use cryopreserved PBMCs were rapidly thawed in a water bath at 371C and washed once in the so-called CTL medium, which consists of RPMI 1640 medium supplemented with 1% Pen/Strep (both Life Technologies, Paisley, UK) and 10% human AB serum (Sigma-Aldrich). After thawing, PBMCs were rested for at least 4 hours in a V-shaped 50 mL tube (Falcon BD, Heidelberg, Germany) in CTL medium, at a concentration of 5-10Â10 6 /mL, and incubated at 371C in a humidified atmosphere at 5% CO 2 . To allow gas exchange the tube cap was loosened. Afterward, living PBMCs were counted using trypan blue staining.
Generation of pp65-specific and IE1-specific T Cells by MLPCs
In this study, we analyzed 8 CMV-seropositive normal donors after stimulation with either pp65 or IE1 CMV antigens and observed the biological profiles within the same donors. The induction of CMV-T-cell lines was performed as previously described 8 with some modifications. PBMCs were resuspended in CTL medium at 10 Â10 6 /mL. Either CMV-pp65 or CMV-IE1 antigenic peptide pool spanning the entire CMV respective proteins (PepTivator; Miltenyi Biotec, Bergisch Gladbach, Germany) were directly added to PBMCs (20 mL of stock solution at 50 mg/ mL for 10 7 cells) in a V-shaped 50-mL Falcon tube and the cultures were maintained at 371C and 5% CO 2 for 2 hours. To allow gas exchange the tube cap was loosened. Upon stimulation, 2 consecutive washing steps in CTL medium were performed. Cells have been plated in 24-well plates (BD Falcon) at a density of 3 Â10 6 /mL in a final volume of 1 mL (day 0). On day 3, recombinant human interleukin (IL)-2 (50 IU/mL) was added. Starting on day 5, halfmedium change and supplementation of IL-2 were performed every other day until day 12.
Evaluation of the Enrichment of CMV-T Cells by Flow Cytometry
After a total of 12-13 days' culture, an aliquot of MLPC was harvested and the frequency of peptide-specific CD3 + T cells was evaluated by flow cytometry by either CD154 + upregulation or by intracellular cytokine staining (ICS) in combination with CD107a degranulation assay.
CD154 Activation Marker Expression
About 5 Â10
5 PBMCs seeded in 200 mL were stimulated for 6 hours in flat-bottomed 96-well culture plates (BD Falcon, Devon, UK) with 1 mg/mL of CMV-pp65 or CMV-IE1 Peptivator and incubated at 371C/5% CO 2 . Cultures were stimulated in the presence of 1 mg/mL anti-CD40 antibody (clone HB14; CD40 pure-functional grade; Miltenyi Biotec), to prevent the downregulation of CD154 expression on T cells induced by interaction with CD40 on antigen-presenting cells (APCs). Samples for negative control were left untouched, whereas human Cytostim (polyclonal stimuli that cause rapid activation of T cells; Miltenyi Biotec) was used at 1 mg/mL as positive control. 9 Samples were taken at 6 hours and stained with anti-CD154-PE, anti-CD3-ECD, anti-CD4-FITC, and anti-CD8-PeCy7 as described further.
ICS Combined With CD107a Degranulation Assay
Degranulation of activated T cells is a necessary precursor of cytolysis and involves the marker CD107a, present in the membrane of cytotoxic granules and exposed onto the cell surface as a result of T-cell activation. 10 Simultaneous characterization of cytolytic and cytokinesecreting effector functions can elucidate the functional patterns of CMV-pp65 and CMV-IE1-specific CTLs. 11 The cytotoxic activity of CMV-T was evaluated by CD107a degranulation assay targeted on IFN-g-producing T cells as recently described 12 with some modifications. The assay has been performed on PBMCs at day 0, on MLPCs at day 11, and at the end of the culture. Peptide was directly added to the aliquot of T-cell lines without any APC and cytokines.
Cells were harvested and seeded at 5 Â 10 5 cells per well in a 96-well U-bottom plate (BD Falcon) and cocultured for 1 hour with either PepTivator CMV-pp65 or PepTivator CMV-IE1, or left unloaded as control. After 1 hour, Brefeldin A (Sigma-Aldrich) and GolgiStop (BD Biosciences), a Golgi-blocking agent to preserve the generated cytokines within the cytoplasm, were added to each well. The cells were stained with CD107a APC immediately (all but isotype control). Phorbol 12-myristate 13-acetate (PMA)/Ionomycin (both from Sigma-Aldrich) were used to obtain a positive control.
After 18 hours of incubation cells were harvested, permeabilized, and stained for intracellular IFN-g apart from surface markers before subjection to flow cytometry acquisition. Antibodies for the surface markers were added and incubated for 15-20 minutes at 41C in the dark. Two consecutive washing steps were performed. Cells were permeabilized by adding 250 mL of 1Â Permeabilizing Solution 2 (Perm2; BD Biosciences) for 12 minutes at RT in the dark. IFN-g PE was added directly in the left flow after 2 washing steps and incubated for 20 minutes at 41C in the dark. At the end, cells were suspended in 200 mL of washing buffer and subjected to flow cytometry analysis.
Analysis of T-Cell Subsets
We analyzed the T-cell phenotypes of CMV-T upon paired pp65-specific and IE1-specific MLPCs within the same subject and compare it with the cognate PBMCs before stimulation (n = 8). Surface staining was performed with saturating conditions of the following antibodies: anti-CD62L (clone DREG56) and anti-CD45RA (clone 2HG-RD1 
Antibodies and Flow Cytometric Analysis
Antibodies used for phenotyping were as follows: anti-CD3-ECD (clone UCHT1), anti-CD4-FITC (clone 13B8.2), anti-CD8-PeCy7 (clone T8), anti-CD56-APC (clone N901), anti-CD14-APC (clone RMO52), anti-CD45RA-PE (clone 2HG-RD1; all from Beckman Coulter, 
Th1/Th2 Cytokine Production
Supernatants were collected from MLPCs at day 12 upon 6 and 18 hours from rechallenge with the cognate pp65 or IE1 peptide pool and stored at À801C until use. Supernatants from respective MLPC without prior restimulation were used as negative controls. The Cytometric Bead Array assay (CBA, human Th1/Th2 cytokine kit; BD Biosciences) was used to quantify the level of soluble IL-2, IL-4, IL-5, IL-10, IFN-g, and TNF-a. Cytokine bead standards were used where the concentration of recombinant protein in each serial dilution allowed for the construction of a standard curve using the mean fluorescence intensity from each bead standard. A minimum of 20,000 of events were acquired by BD FACSCanto II device (Becton Dickinson). Analysis of acquired data was performed using FCAP ARRAY Software version 1.0.1 (Soft Flow Hungary Ltd, Pecs, Hungary). The concentration of cytokine was calculated using the standard curve and expressed as a net value (pg/mL) after subtraction of the unstimulated control (Supplemental Digital Content 1, Table I , http://links. lww.com/JIT/A448). Supernatants upon pp65 and IE1 restimulation of MLPCs where the CMV-T enrichment failed (specific T cells <0.001%, donors number 2 and 3 in Table 2 ) were used as a further negative control.
Isolation of CMV-T Cells After MLPCs
In selected experiments, on the basis of the entity of the proliferation of CMV-T during MLPC, restimulation of the whole culture was performed on day 13 by using the same peptide pool as of day 0, followed by positive selection either by IFN-g Secretion Assay-Cell Enrichment and Detection Kit or by CD154 MicroBead Kit (both Miltenyi Biotec), performed according to the manufacturer's instructions. In general, a good enrichment of CMV-T was feasible when starting with a frequency of CD3 + antigenspecific T cells at the end of the MLPCZ10%.
Magnetic Selection by IFN-c Capture (CCS)
All steps, but the secretion period, have been performed by keeping cells cold and by using precooled solutions to prevent capping of antibodies on the cells surface and a nonspecific cell labeling. Upon stimulation with peptides for 4 hours, the cells have been labeled with IFN-g Catch Reagent and incubated on ice for 5 minutes. Warm medium was then added to allow cytokine secretion, cells were incubated in a closed tube for 45 minutes at 371C, and turned every 5 minutes to resuspend them. Labeling was performed for 10 minutes on ice using 20 mL of IFN-g Detection Antibody-PE per 10 7 total cells in 80 mL of CliniMACS buffer (PBS pH 7.2, 0.5% BSA, and 2 mM EDTA). After 15-minute incubation with anti-PEMicroBeads at 41C (20 mL/10 7 cells) in 80 mL of CliniMACS buffer, the cell suspension was enriched using MS or LS columns on a MiniMACS or MidiMACS.
Magnetic Selection by CD154 MicroBead
After 6 hours from in vitro stimulation, cells were labeled with CD154-Biotin (10 mL/10 7 cells) for 15 minutes at 41C. After a 15-minute incubation with Anti-Biotin MicroBeads at 41C (20 mL/10 7 cells) in 80 mL of CliniMACS buffer, the cell suspension was enriched using MS or LS columns on a MiniMACS or MidiMACS. Magnetic separation was performed according to the manufacturer's recommendation and isolation was identical for both selection methods. We then used cells collected from the unlabeled fraction as a convenient source of antigen preloaded feeder cells to be cocultured with isolated CMV-T after MLPC. These cells were immobilized using mitomycin C treatment. 13 
Antigen-specific Proliferation
To assess whether the generated CMV-T can appropriately divide after stimulation with endogenously processed antigen, CMV-T obtained immediately upon isolation by CD154 magnetic enrichment from MLPCs (day 13) were labeled with carboxyfluorecein diacetate succimidyl ester (CFSE; CellTrace CFSE Cell Proliferation Kit; Invitrogen, Molecular Probes, Eugene, OR) and were cocultured for 6 days with autologous feeder cells [mitomycin C (SigmaAldrich)-treated PMBCs from the unlabeled negative fraction]. Fluorescence labeling of PBMCs and generated T-cell lines was achieved as described 14 with some modifications. Briefly, cells were washed in RPMI 1640 medium containing 10% AB serum and labeled at a density of 1Â 10 6 cells/ mL with 1 mM of CFSE. Cells were incubated with the dye at 371C for 10 minutes. Staining was quenced by the addition of 5 volumes of ice-cold CTL medium to the cells. After 5 minutes of incubation on ice, cells were centrifugated at 400g for 10 minutes at 41C. Labeled cells were washed a further 2 times and plated in a round-bottomed 96-well plate (BD Falcon) with autologous mytomycintreated PBMCs preincubated with 1 mg/mL of CMV Peptivator at a ratio of 1:10. CTL medium included 50 IU/mL IL-2 and 1 mg/mL phytohemagglutinin-L (PHA-L; SigmaAldrich). For exclusion of unspecific proliferation, feeder cells and autologous negative fraction (CFSE labeled and unlabeled) alone as negative controls were used. After 6 days, cells were harvested, counted, and stained with anti-CD3, anti-CD4, and anti-CD8 before acquisition of a minimum of 10,000 CD3 + CFSE + events on a Cytomics FC500 (Beckman Coulter).
Statistics
The results obtained upon stimulation with pp65 were compared with those obtained upon stimulation with IE1 for all donors. Both stimulations were carried out in the same donor's cells to avoid biases due to donor effect (not to the different stimulating peptide). Unless otherwise specified, data are expressed as mean ± SD. Experimental data were evaluated in a paired manner using the Student t test. Reported P-values are 2-sided and were considered statistically different if *P < 0.05, **P < 0.005, and ***P < 0.001.
RESULTS
Antiviral CD8 + and CD4 + T Cells in Healthy Subjects
We tested PBMCs and MLPCs in peptides titration assays to identify possible effects of peptide pools concentration on antigen sensitivity. Frequencies of IFN-g-secreting CMV-T in PBMCs were not significantly different upon stimulation with either 0.5 or 1 mg/mL of both peptide pools (Fig. 1A) + T-cell responses decreased upon exposure to peptide pool concentrations ranging from 1 to 0.01 mg/mL (Fig. 1B) . Accordingly, we decided to use 1 mg/mL of peptide mix for both CMV epitopes during in vitro stimulation of either PBMCs or MLPCs.
We were able to detect the frequencies of CD3 + CMV-T in PBMCs from 8 healthy donors, upon stimulation with CMV-pp65 and CMV-IE1 peptide pools ( Table 1 ). 15, 16 pp65-specific and IE1-specific CD3 + CD8 + T cells ranged from <0.01% to 1.56% (median: 0.17%) for the former and from 0.05% to 3.61% (median: 0.66%) for the latter. Median frequency of pp65-specific and IE1-specific CD3 + CD4 + T cells was 0.34% (range, <0.01%-2.89%) and 0.17% (range, <0.01%-4.79%), respectively.
Heterogeneity of Degranulating CMV-specific CD8 + T Lymphocytes in PBMCs
We applied a combined assay to provide simultaneous assessment of 2 critical CD8 + T-cell effector functions: cytokine production and CD107a degranulation in response to stimulation with the antigen. CD107a is a marker present in the membrane of cytotoxic granules and it is exposed onto the cell surface as a result of degranulation. Following in vitro stimulation, CMV-specific CD8 + T lymphocytes were heterogenous with regards to the composition of cells positive for CD107a. There was no linear relationship of IFN-g secretion and CD107a degranulation in the CD3 + CD8 + population from the same sample (Fig. 2) . Indeed, even if expressing CD107a at high levels, CD8 + T cells in the same gated population were poorly positive for IFN-g (Fig. 2, bottom right quadrant) . The most frequent situation involves the bottom left panel in the Figure 2 , where are plotted either pp65-specific or IE1-specific polyfunctional CTLs expressing very low levels of both IFN-g and CD107a activation markers. The 80% of analyzed antigen-specific CTLs that expressed a fair amount of IFN-g (in the range of 1%-4%), whereas almost negative for CD107a (range, 0.2%-0.4%) were IE1 CTLs (Fig. 2, upper left quadrant) . Median degranulation of CTLs in PBMCs upon stimulation with CMV-pp65 and CMV-IE1 peptides was 0.46% (range, <0.01%-6.51%) and 0.13% (range, <0.01%-7.99%), respectively. CD3 + CD4
+ antigen-specific T cells were negative for CD107a (data not shown).
Composition of the MLPCs and Variable Enrichment of Viral Antigen-specific T Cells
In PBMCs from healthy donors, background expression of specific activation markers or secretion of cytokine (ie, CD154, CD137, IFN-g, IL-2, TNF-a) in the unstimulated sample are generally very low. 17, 18 We induced MLPCs to expand cognate antigen-specific T cells from healthy donors serologically positive for CMV before selection by both CCS and CD154 microbeads. PBMCs purity after density gradient separation was 92.4% ± 1.7% (n = 6 , respectively. The ratio of CD4 + and CD8 + T cells within the Tcell populations was determined by flow cytometry before stimulation with peptides (PBMC at day 0) and after the short-term MLPCs (at day [11] [12] [13] . A predominance of CD4 + T cells was shown in all cases, either at day 0 or after 11-13 days, regardless of the CMV epitope used as stimulant to begin the antigen-specific culture (Fig. 3) . MLPC obtained by priming with pp65 peptides pool were composed of 26.05% ± 8.82% CTLs compared with 67.15% ± 12.55% Th. MPLCs obtained by priming with IE1 peptides pool were composed of 28.60% ± 10.86% CTLs compared with 57.53% ± 5.09% Th. The magnitude of responses varied depending on the epitope, peptide, and donor (Table 2) . Median cell viability from all samples at day 11 upon CMV-pp65 stimulation was 31.6% (range, 6.0%-84.3%), whereas only 13.8% (range, 2.3%-81.7%) upon stimulation with CMV-IE1. Cells stimulated with pp65 were 10.5 ± 8.5 Â10 6 and only 4.7 ± 6.1Â 10 6 were alive upon IE1 induction of MLPC. In the latter case, all cultured cells were used to check for the IE1-specific frequency at flow cytometer. As shown in Figure 4 , by considering the absolute CMV-T numbers we could better appreciate the wide spectrum of fold increase, upon MLPC, among the donor-specific and antigen-specific cell lines (pp65 specific vs. IE1 specific) and the way to check for their specificity (IFN-g + vs. CD154 + ). The rate of increase of pp65-specific T cells was 1-to 33-fold, whereas IE1-specific T cells ranged from 1-to 961-fold under the same experimental conditions.
Good enrichment of CMV-pp65-specific cells was achieved in 3 out of 8 samples (Table 2) , when starting with a frequency of CD3 + antigen-specific cells Z10% before restimulation and selection (results are shown for 1 representative T-cell line in Fig. 5 ). We failed to further expand CMV-T in 62% of cases despite improving the total recovery by performing a repeated purification step with a new column, for each sample (unlabeled cells from the first column were loaded onto a new one; the obtained positive fractions from each column were combined before coculturing them with feeder cells).
Pp65-specific and IE1-specific T Cells Show a High Proliferation Rate After Antigenic Rechallenge
To assess whether the generated CMV-T can appropriately divide after restimulation with endogenously processed antigen, T cells were labeled with CFSE and were cocultured for 6 days (from day 1 to day 7 after selection) with autologous feeder cells (mitomycin-C-treated PMBCs from the unlabeled negative fraction) in 1:20-1:60 ratios. Proliferation potential was assessed on CMV-T obtained upon enrichment by MLPC and selection by CD154 microbeads. The isolated CMV-T showed high antigenspecific proliferation compared with the negative control (Fig. 6 ). As shown, autologous feeder cells did not proliferate during 6 days of expansion. Mitomycin-C treatment was accountable for this lack of proliferation; indeed, peptide-preloaded autologous PBMCs grew out up to 50% during culture (Fig. 6, upper Healthy volunteers were the same as used to assess CMV-T frequencies in PBMCs at day 0 (Table 1 ). Samples no. 1 and 6: frequencies assessed by ICS; samples no. 4, 5, 7, and 8: frequencies assessed by CD154 staining. Background values as determined in unstimulated controls are subtracted before calculating the % of CMV-T. Gray shadows point out samples that further allowed CMV-T expansion after MLPC restimulation. MLPC failed in 2 out of 8 cases because the cells had died after 12 days of culture (donor number 2 and 3). We can presume that the standard predetermined peptide load, used for the first stimulation of PBMCs, was not optimal for those specific lots. Indeed, it has been shown in previous reports focused on T cells immunoassays and epitopes discovery that the HLA repertoires show different affinity toward immunodominant epitopes upon stimulation with peptides. 19, 21, 22 CMV-T indicates CMV-specific T cells; ICS, intracellular cytokine staining; MLPCs, mixed lymphocytes peptide cultures; NA, not available; PBMCs, peripheral blood mononuclear cells. CMV-T underwent at least 1 cell division, as measured by loss of intensity in the CFSE signal after a short period of expansion. The extent of this latter proliferation was not dependent on the CMV-T:feeder cells ratio, in our hands, as the proliferation rate was almost identical at 1:20, 1:40, and 1:60 (data not shown).
Multicytokine Repertoire After MLPCs was IFN-
The cytokines secretion by MLPCs was analyzed to compare the CMV epitope-specific expression profile in samples at 2 different time points. MLPCs from PBMCs of CMV-seropositive healthy subjects were stimulated with pp65 or IE1 overlapping peptides spanning the entire immunodominant CMV proteins. After 6 and 18 hours, aliquots of supernatants were taken and evaluated for the release of IL-2, TNF-a, IFN-g, IL-4, IL-5, and IL-10. The secretion repertoire was mainly IFN-g + TNF-a + polarized with high levels of IL-4 and IL-10 upon pp65 and IE1 reload, respectively (Fig. 7 ). Median IFN-g level was higher at 18 hours' collection time compared with earlier collection time for both CMV antigens. In contrast, TNF-a secretion was less appreciable at 18 hours for both pp65 and IE1. Anyhow, TNF-a absolute concentration was higher upon pp65 stimulation. Median IL-2 concentration was unexpectedly very low regardless of CMV epitope and collection time, when considering both mean and median values ( Fig. 7 and Table 3 ), whereas IL-5 secretion seems appreciable only after 18 hours stimulation period, albeit representing <10% of the overall Th1/Th2 secretion pattern. In general, we observed a wide and heterogenous secretion pattern among different MLPCs and, from an absolute quantitative point of view (cytokine concentration) the amount of each measured cytokine was even higher in the pp65-specific cultures. As expected, in the case of supernatants upon pp65 and IE1 restimulation of MLPC with no detectable CMV-T (< 0.01%), there was no expression of Th1/Th2 cytokines, alike those from unstimulated MLPCs (data not shown).
Single Antigenic Stimulation Significantly
Reduces the Level of pp65-specific and IE1-specific Late Effector CD8 + T Cells
To evaluate and compare the distribution of different T-cell subsets among antigen-specific cultures, we analyzed the phenotypic profile of MLPCs and their cognate PBMCs. The largest subpopulation in the T-cell phenotypes of both PBMCs and MLPCs was formed by T cells of late effector stages (Fig. 8A) . Expanded CMV-T had significantly lower level of Temra CTLs compared with PBMCs before CMV stimulation (MLPC_pp65: 78.48% ± 11.05%, P < 0.005; MLPC_IE1: 77.82% ± 9.03%, P < 0.001; PBMCs: 97.5% ± 1.4%). Temra Th were less represented upon MLPC_IE1 (51.07% ± 11.52%, P < 0.05%; PBMCs: 71.0% ± 13.6%). CMV-T expansion was accompanied by a significant increase of Tn / scm CTLs (MLPC_pp65: 8.23% ± 4.28%, P < 0.001; MLPC_IE1: 14.12% ± 4.91%, P < 0.001; PBMCs: 1.0% ± 0.9%). Tn / scm Th counterpart significantly increased only upon stimulation with IE1 (20.25% ± 9.67% vs. 5.1% ± 3.6%, P < 0.005.). Tcm made up the smallest subpopulation upon expansion (MLPC_ pp65: 3.32% ± 3.63%; MLPC_IE1: 4.88% ± 2.34%).
The phenotypes of magnetically enriched CD154 + fractions from IE1 and pp65 cultures were investigated after 6 days of expansion by culture with different amount of antigen reloaded autologous feeder cells (Fig. 8B) . The overall CMV-T population encompasses 2 designated regions in the FSC/SSC gate, the smallest named "T1" and the contiguous named "T2" of wider area, holding activated and bigger CMV-T at higher granularity. CMV-T after magnetic enrichment displays an effector phenotype with cells that belong to T1 region equally composed of Tem and Temra cells and CMV-T that belongs to T2 gate, mainly Tem, with a lower proportion of Temra (Figs. 8B, C) . As shown in Figure 8B (left panels), the CMV-T:feeder cells ratio did not affect neither the expansion outcome nor the composition of the final T-cell subpopulations.
DISCUSSION
This study focuses on the biological effects of antigenspecific T cells stimulation in PBMCs from CMVseropositive healthy donors. We evaluated the in vitro behaviors of the enriched pp65 and IE1 CMV-T after a short expansion period and compared the functional patterns among the obtained cells.
CMV-T activation relies on the recognition of strongly immunogenic viral epitopes differently involved in the reactivation of the virus and with heterogenous level of expression. [21] [22] [23] [24] To date, both pp65 and IE1 are considered dominant T-cell targets, whereas the past research mainly concentrated on pp65 only. Some studies confirmed a positive correlation between immune reconstitution after HSCT and rising number of pp65-specific T cells. 25, 26 Unfortunately, IE1-specific CD3 + T cells were not included in these investigations or, when included, they were mixed with the cognate pp65-specific ones in the data analysis, or even earlier, so that at the end pp65-specific and IE1-specific T cells were generically called "CMV-specific T FIGURE 6. Proliferation potential by CFSE staining of antigen-specific T cells isolated after MLPC according to their expression of CD154. IE1-specific T cells were labeled with CFSE immediately upon selection by anti-CD154 microbeads, performed after the 13-day MLPC period, and incubated for 6 days with mitomycin-treated autologous feeder cells (PBMCs from the unlabeled negative fraction after selection). For exclusion of unspecific proliferation, feeders alone (upper middle panel) and autologous negative fraction (upper right panel) were used as negative controls. Levels of proliferation were determined by CFSE fluorescence loss in flow cytometry (lower panels). Loss of the CFSE intensity is shown for the gated region in the morphologic FSC/SSC plot at both day 3 and day 6 after MACS selection. The overlay of the plots at day 3 and 6 shows that almost all CMV-T proliferated at the end of the assay. This experiment has been performed 2 times with either pp65-specific or IE1-specific T cells and similar results have been obtained. CFSE indicates carboxyfluorecein diacetate succimidyl ester; FSC/SSC, forward scatter/side scatter.
lymphocytes." [27] [28] [29] Finally, a recent finding showed that dominance and magnitude (relative frequencies) of the IE1-specific but not the pp65-specific CD8 + T-cell response correlate with protection from CMV disease in 27 heart and lung transplant recipients, even though factors apart from the entity of the CD8/IE1 response were conferring protection. 30 A major strength of our study was the comparison between IE1-specific and pp65-specific T cells biological features obtained from paired samples. Our data showed that IE1-specific CTLs were more than pp65-specific CD3 + CD8 + T cells (Table 1) , in agreement with the literature. 31 Despite this, the median CD107a degranulation by IE1-specific CTLs was lower than the pp65-specific cytotoxic counterpart and there was no correlation between the frequency of IFN-g-producing T cells and their cytotoxic potential (Fig. 2) . Although the CD107a degranulation assay does not directly provide cytotoxicity of CMV-T, it measures a functional response to antigenspecific stimulation so it reflects the activation status of CMV-T. As expected and in keeping with other studies, our results showed heterogeneity, supporting that HLA may have a major effect on immune response. Stimulation with peptide pools (spanning the entire CMV protein sequence), including broadly immunogenic and conserved pp65 and IE1 epitopes, seems to be especially important for viral T-cell expansion to recruit effector cells with different precursor frequencies and affinities for the target antigen, which may reduce the risk of viral escape mutants. 32 Another advantage of overlapping peptide pools is that both CD4 + and CD8 + virus-specific T cells can be obtained, which may promote the survival and persistence of the generated T cells after ACT. [33] [34] [35] Using overlapping peptides, CD3 + T-cell responses can be detected to multiple epitopes, regardless of HLA type. Here we used pp65 and IE1 libraries as stimulating antigens to generate a coordinated and simultaneous activation of both CD8 + and CD4
+ CMV-T response from CMV-seropositive donors' peripheral blood and to be independent from donors' HLA type, as the latter was not known before stimulation. However, healthy donors differ in HLA background. Epitope dominance and variability in the relative numbers of CD4 and CD8 effector cells and IFN-g production among normal donors could reflect individual CMV-specific cellular immunity. 36 These variables would likely result in differences in the degree of T-cell responsiveness to epitopes presented in the peptide pool, some of which might have not been optimally presented in our experimental setting. Indeed, cell viability after MLPC_IE1 was only 13.8%, the range of the observed viability among cellular lots was really wide (2.3%-81.7%), and CMV-T fold-increase upon short-term culture showed a distinct behavior based on the stimulus originally used to activate them and on the way their functionality (ICS vs. CD154 upregulation) was measured.
Besides the evaluation of the enrichment of CMV-T during MLPCs by flow cytometer (Tables 1 and 2 and Fig. 4) , we isolated, when feasible, CMV-T after MLPCs by either CCS or CD154 MACS selection. IFN-g capture enables the rapid enrichment of both CD4 + and CD8 + virus-specific cells but only a subset of virus-specific + , and late effector T cells (Temra) as CD62L À CD45RA + /CD45RO À . A, Expanded CMV-T by MLPCs revealed a significant reduction of cytotoxic Temra compared with PBMCs before CMV stimulation. Upon stimulation with IE1, MLPC resulted in a significant lower percentage of helper Temra too, but in a lesser extent compared with CTLs counterpart. Otherwise in MLPCs from both pp65 and IE1 stimulation, the cytotoxic subsets of Tn/scm were higher compared with PBMCs. Symbols stand for ***P < 0.001, **P < 0.005, *P < 0.05 by 2-way analysis of variance of paired samples. Data are pooled from 6 independent experiments. The phenotypes of magnetically enriched positive fractions CD154 + from MLPC_IE1 (B) and MLPC_pp65 (data not shown) were investigated after 6 days of expansion by culture with different ratio of antigen preloaded autologous feeder cells. The overall population of CMV-T encloses both T1 and T2 regions in the FSC/SSC gate. T1, smaller CMV-T; T2, bigger and granulous activated CMV-T. C, CMV-T that belongs to T1 region are equally composed of Tem and Temra. Conversely, CMV-T that belongs to T2 region are mainly Tem with a lower proportion of Temra. This experiment was also performed from MLPC_pp65 and similar results were obtained.
T cells secrete IFN-g on activation and a significant number of human immunodeficiency virus epitope-specific CTLs detected by tetramer binding do not produce IFN-g. 37, 38 Different T-cell surface molecules that are selectively expressed or strongly upregulated after T-cell activation could similarly be useful for the selection of antigen-specific T cells. Of these, CD137 and CD154 were recently the object of studies exploiting their antigen-induced expression. This aspect makes CD137 and CD154 promising candidates for the selection of CMV-T at a clinical level. 19, [39] [40] [41] We showed specificity and sensitivity of the CD154 upregulation-based CMV-T isolation method, which allowed simultaneous enrichment of CD4 + and CD8 + pathogen-specific T cells (Figs. 4-6 and our previous preliminary results 42 ). The purity of antigen-specific T cells after MACS selection with paramagnetic beads and after an additional short expansion phase seems to be correlated with the frequency of antigen-specific T cells before enrichment. 9 Purity of the obtained CMV-T upon magnetic enrichment was not evaluated in this study. In samples with lower CMV-T at day 11 of MLPC (Table 2) , a higher percentage of contaminating CD154 or IFN-g negative cells was supposed to affect the expansion outcome. To assess whether there was a correlation between the frequency of CMV-pp65 or CMV-IE1 reactive T cells in the starting population and the yield or purity of the enriched fractions after MLPC, the samples should have been evaluated by flow cytometer. Compared with the CCS, direct selection by CD154 microbeads appeared in our hands less laborious and with fewer critical steps. Indeed, despite the CMV-T isolation methodology based on cytokine secretion showed similar sensitivity and specificity along with a greater balance between CD4 + and CD8 + CMV-T isolation, 42 it requires several additional washing steps and the use of ice-cold reagents to avoid unspecific background. In contrast, a protocol for the automated isolation of antigenspecific T cells based of IFN-g secretion upon stimulation with clinical-grade CMV-pp65 or CMV-IE1 peptide pools is already available at clinical level since a decade, and CCS now moves toward clinical routine. In addition, the easy generation of pathogen-specific T-cell lines on the basis of IFN-g + and/or expression of CD137 and CD154 has been recently described, but both approaches result in different T-cell population, which may lead to divergent T-cell responses in vivo. 40 Finally, the experimental need of the anti-CD40 antibody addiction to allow CMV-T selection by CD154 upregulation potentially limits its translability.
IE1-specific or pp65-specific T cells were isolated in vitro according to their CD154 expression from MLPC at day 13-14. After 6 days of in vitro expansion, the specificity of the isolated T cells was confirmed by the expression of the activation marker CD154 (Fig. 5) and by the CFSE-based proliferation assay (Fig. 6) .
We then explored the repertoire of cytokines secreted by pp65-specific and IE1-specific T lymphocytes upon antigenic reload. Stimulation with CMV-IE1 caused the release of a considerable amount of IL-10, beside the expected Th1-type cytokines IFN-g and TNF-a, at both 6 and 18 hours collection times (Fig. 7) . Each measured cytokine was specifically secreted upon stimulation, as no cytokine secretion was present without stimulus or without CMV-T in the MLPC. The finding that IL-10 secretion was so high in the MLPC_IE1 is consistent with the hypothesis that the Th lymphocytes that were part of the MLPC T-cell repertoire (Fig. 3) possess a regulatory-like phenotype.
Indeed, some recent reports describe the existence in human blood of a type 1-T cells lineage producing both IFN-g and IL-10, but not IL-2. 43, 44 The CBA assay does not allow to distinguish between CD4 + -secreting and CD8 + -secreting T cells, as it is not an approach at single-cell level but population based. Even if we cannot get information on polyfunctionality of CMV-T, these results showed that IL-10 and/or IL-4 were secreted only when IFN-g and/or TNF-a were also present ( Fig. 7 and Table 3 ).
Finally, we investigated the phenotype of T-cell subsets by flow cytometer analysis of CD62L and CD45RA as markers of T-cell maturation, showing that CMV-T in the bulk of MLPC were mainly Temra (Fig. 8A) but >80% of activated CMV-T after magnetic enrichment was Tem (Figs. 8B, C) . Historically, the most pressing technical issue in ACT therapies has been the generation of a sufficient quantity of antigen-specific T cells for transfer rather than to identify T cells subsets that possess superior traits for adoptive immunotherapy. 45 However, extensive culturing of antigen-specific T cells has been shown to efficiently diminish alloreactivity and concurrently limit the proliferative capacity of the transferred T cells in vivo. 14, [46] [47] [48] It is now clear from relevant preclinical animal models and detailed retrospective analyses of human clinical trials that infusion of the less-differentiated T-naive, T-memory stem cells, and T-central memory subsets is associated with superior T-cell engraftment, persistence, and antitumor immunity compared with T-effector memory and terminally differentiated short-lived effector T cells. 49 Upon reexposure to antigen, memory T cells respond more rapidly and robustly than naive T cells, providing better clearance of pathogens. Recent reviews have reinforced the text-book view that memory T cells arise from effector cells. Although this is an appealing notion, emerging data are more consistent with a model where naive cells directly develop into memory cells without transitioning through an effector stage. [50] [51] [52] Recent studies at single-cell level cast a spotlight on the issue of the lineage relationships between memory and effector cells, paving the way for profound implications in the development of effective T-cell-based therapies. [53] [54] [55] In conclusion, in the current study, we aimed at improving basic knowledge on pathogen-specific T cells biology and functional behavior. We established analytical methods focused on in vitro preclinical CMV-T generation and on T-cell monitoring techniques. As for many assays involving T-cell stimulation, outcome was variable, depending on multiple factors such as donor and viral epitope, experimental stimulation, and culture conditions. Notably, differences in HLA and epitope dominance and variability in the relative number of CD3 + effector cells and IFN-g/ CD154 expression among healthy donors could reflect the observed individual CMV-specific cellular immunity.
